Bollard Group LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$7,000
-30.0%
1,2730.0%0.00%
Q4 2021$10,000
-9.1%
1,2730.0%0.00%
Q3 2021$11,000
-26.7%
1,2730.0%0.00%
Q2 2021$15,000
-6.2%
1,2730.0%0.00%
-100.0%
Q1 2021$16,000
-20.0%
1,2730.0%0.00%0.0%
Q4 2020$20,000
+66.7%
1,2730.0%0.00%
Q3 2020$12,000
+9.1%
1,2730.0%0.00%
Q2 2020$11,0001,2730.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders